Abstract
Abstract

Background
Hospitalizations among people with dementia (PWD) may precipitate behavioral changes, leading to the psychotropic medication use despite adverse outcomes and limited efficacy. We sought to determine the incidence of new psychotropic medication use among community‐dwelling PWD after hospital discharge and, among new users, the proportion with prolonged use.


Methods
This was a retrospective cohort study using a 20% random sample of Medicare claims in 2017, including hospitalized PWD with traditional and Part D Medicare who were 68 years or older. The primary outcome was incident prescribing at discharge of psychotropics including antipsychotics, sedative‐hypnotics, antiepileptics, and antidepressants. This was defined as new prescription fills (i.e., from classes not used in 180 days preadmission) within 7 days of hospital or skilled nursing facility discharge. Prolonged use was defined as the proportion of new users who continued to fill newly prescribed medications beyond 90 days of discharge.


Results
The cohort included 117,022 hospitalized PWD with a mean age of 81 years; 63% were female. Preadmission, 63% were using at least 1 psychotropic medication; 10% were using medications from ≥3 psychotropic classes. These included antidepressants (44% preadmission), antiepileptics (29%), sedative‐hypnotics (21%), and antipsychotics (11%). The proportion of PWD discharged from the hospital with new psychotropics ranged from 1.9% (antipsychotics) to 2.9% (antiepileptics); 6.6% had at least one new class started. Among new users, prolonged use ranged from 36% (sedative‐hypnotics) to 63% (antidepressants); across drug classes, prolonged use occurred in 51%. Predictors of newly initiated psychotropics included length of stay (≥median vs. <median; aOR 1.5, 95% CI: 1.4–1.6) and delirium (aOR 1.8, 95% CI: 1.7–1.9).


Conclusions
Hospitalized PWD have a high prevalence of preadmission psychotropic medication use; against this baseline, discharge from the hospital with new psychotropics is relatively uncommon. Nevertheless, prolonged use of newly initiated psychotropics occurs in a substantial proportion of this population.
Topics

No keywords indexed for this article. Browse by subject →

References
42
[2]
Assessment and management of behavioral and psychological symptoms of dementia

H. C. Kales, L. N. Gitlin, C. G. Lyketsos

BMJ 10.1136/bmj.h369
[4]
Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US

Donovan T. Maust, Julie Strominger, H. Myra Kim et al.

JAMA 10.1001/jama.2021.1195
[10]
National Trends in Potentially Preventable Hospitalizations of Older Adults with Dementia

Timothy S. Anderson, Edward R. Marcantonio, Ellen P. McCarthy et al.

Journal of the American Geriatrics Society 10.1111/jgs.16636
[14]
Identifying Medicare Managed Care Beneficiaries from the Master Beneficiary Summary or Denominator Files. ResDAC. Accessed March 15 2022.https://resdac.org/articles/identifying-medicare-managed-care-beneficiaries-master-beneficiary-summary-or-denominator
[16]
Healthcare Cost and Utilization Project (HCUP) SID Notes. Accessed May 3 2022.https://www.hcup-us.ahrq.gov/db/vars/siddistnote.jsp?var=i10_serviceline
[18]
A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative Data

Carl van Walraven, Peter C. Austin, Alison Jennings et al.

Medical Care 10.1097/mlr.0b013e31819432e5
[19]
Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data

Hude Quan, Vijaya Sundararajan, Patricia Halfon et al.

Medical Care 10.1097/01.mlr.0000182534.19832.83
[20]
Ingram D "NCHS urban–rural classification scheme for counties. National Center for Health Statistics" Vital Health Stat (2014)
[24]
Medi‐Span: Drug Data Solutions for Healthcare. Accessed March 17 2022.https://www.wolterskluwer.com/en/solutions/medi-span
[39]
Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia

Donovan T. Maust, Hyungjin Myra Kim, Lisa S. Seyfried et al.

JAMA Psychiatry 10.1001/jamapsychiatry.2014.3018
Metrics
8
Citations
42
References
Details
Published
Dec 13, 2022
Vol/Issue
71(4)
Pages
1134-1144
License
View
Authors
Funding
National Institute on Aging Award: 1R24AG064025
Agency for Healthcare Research and Quality Award: K12HS026383
Cite This Article
Matthew E. Growdon, Siqi Gan, Kristine Yaffe, et al. (2022). New psychotropic medication use among Medicare beneficiaries with dementia after hospital discharge. Journal of the American Geriatrics Society, 71(4), 1134-1144. https://doi.org/10.1111/jgs.18161